New York · 2025 Regular Session · Bill

A 10521: Adds CLN2, MPS IVA, MPS VI, MPS VII and Fabry diseases to the newborn screening panel for New York state

In committee Last action April 7, 2026: PRINT NUMBER 10521A

Plain-language summary

A 10521 is a bill introduced in the New York House on March 6, 2026. According to its official title, it concerns: Adds CLN2, MPS IVA, MPS VI, MPS VII and Fabry diseases to the newborn screening panel for New York state. Primary sponsor: Andrew Hevesi (Democratic). It lists 7 additional sponsors. Most recent recorded action (April 7, 2026): PRINT NUMBER 10521A.

Sponsors

Primary sponsor: Andrew Hevesi (Democratic). 7 co-sponsors.